Brief: Sequana Medical Announces Positive Interim Results Of Sahara Desert, Alfapump Dsr® Study

Sequana Medical NV

07/12/2021 06:05

Dec 7 (Reuters) - Sequana Medical NV  SEQUA.BR :
    * SEQUANA MEDICAL ANNOUNCES POSITIVE INTERIM RESULTS OF
SAHARA
DESERT, ALFAPUMP DSR® STUDY IN HEART FAILURE PATIENTS WITH
PERSISTENT CONGESTION
    * RECRUITMENT ON-TRACK TO REPORT TOP-LINE DATA IN H2 2022
    * PROPRIETARY DSR INFUSATE 2.0 DEVELOPMENT ON TRACK TO START
MOJAVE DESERT IN H2 2022
    * LONG-TERM FOLLOW-UP OF RED DESERT PATIENTS SHOWS DURABLE
IMPROVEMENT IN DIURETIC RESPONSE FOLLOWING ALFAPUMP DSR THERAPY

Source text for Eikon:  ID:nGNE64pmLs 
Further company coverage:  SEQUA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))